Literature DB >> 6096193

A controlled trial of a high fibre, low fat and low sodium diet for mild hypertension in Type 2 (non-insulin-dependent) diabetic patients.

P M Dodson, P J Pacy, P Bal, A J Kubicki, R F Fletcher, K G Taylor.   

Abstract

Fifty hypertensive Type 2 (non-insulin-dependent) diabetic patients were allocated, in a controlled trial, to a treatment diet of high fibre, low fat and low sodium composition, or to a control diet by the hospital dietitian. After 3 months treatment, the modified diet-treated group showed a highly significant reduction in mean systolic (180.5 +/- 19.0 to 165.0 +/- 20.7 mmHg) and diastolic blood pressure (96.6 +/- 9.3 to 88.0 +/- 10.5 mmHg), accompanied by significant reductions in urinary sodium excretion (183.0 +/- 62.1 to 121.7 +/- 65.8 mmol/day) glycosylated haemoglobin (12.4 +/- 3.1 to 10.5 +/- 2.9%), weight (74.6 +/- 13.5 to 71.7 +/- 12.1 kg) and serum triglyceride levels (p less than 0.05). The mean values of diastolic pressure (p less than 0.01), urinary sodium/potassium ratio (p less than 0.001), urinary potassium (p less than 0.01) was significantly reduced at 3 months compared to control. No changes in serum HDL-cholesterol levels were observed. The number of patients with normal blood pressure at 3 months was greater in the modified diet-treated group (ten versus five). Treatment of mild hypertension in diabetic subjects with this form of dietary regimen has a hypotensive response, with improvement in glycaemic control and no side effects. This modified diet may be an attractive alternative to anti-hypertensive drug therapy as a first line treatment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6096193     DOI: 10.1007/bf00290388

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

1.  Metabolic effects of beta-adrenoreceptor blockers.

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  Proposals for nutritional guidelines for health education in Britain. Extracts from a consultative document prepared for the National Advisory Committee on Nutrition Education.

Authors: 
Journal:  Lancet       Date:  1983-09-24       Impact factor: 79.321

3.  Error in blood-pressure measurement due to incorrect cuff size in obese patients.

Authors:  M H Maxwell; A U Waks; P C Schroth; M Karam; L P Dornfeld
Journal:  Lancet       Date:  1982-07-03       Impact factor: 79.321

4.  Blood-pressure-lowering effect of a vegetarian diet: controlled trial in normotensive subjects.

Authors:  I L Rouse; L J Beilin; B K Armstrong; R Vandongen
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

5.  Moderate potassium supplementation in essential hypertension.

Authors:  G A MacGregor; S J Smith; N D Markandu; R A Banks; G A Sagnella
Journal:  Lancet       Date:  1982-09-11       Impact factor: 79.321

6.  Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up.

Authors:  M B Murphy; P J Lewis; E Kohner; B Schumer; C T Dollery
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

7.  Controlled, randomised trial of the effect of dietary fat on blood pressure.

Authors:  P Puska; J M Iacono; A Nissinen; H J Korhonen; E Vartianinen; P Pietinen; R Dougherty; U Leino; M Mutanen; S Moisio; J Huttunen
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

8.  Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics.

Authors:  A R Christlieb; J H Warram; A S Królewski; E J Busick; O P Ganda; A C Asmal; J S Soeldner; R F Bradley
Journal:  Diabetes       Date:  1981       Impact factor: 9.461

9.  Randomised controlled trial of a no-added-sodium diet for mild hypertension.

Authors:  T C Beard; H M Cooke; W R Gray; R Barge
Journal:  Lancet       Date:  1982-08-28       Impact factor: 79.321

10.  Timolol treatment after myocardial infarction in diabetic patients.

Authors:  T Gundersen; J Kjekshus
Journal:  Diabetes Care       Date:  1983 May-Jun       Impact factor: 19.112

View more
  9 in total

Review 1.  The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis.

Authors:  S C Bain; P M Dodson
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 2.  Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice.

Authors:  S Vijan; D L Stevens; W H Herman; M M Funnell; C J Standiford
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

3.  A controlled trial of a low sodium, low fat, high fibre diet in treated hypertensive patients: the efficacy of multiple dietary intervention.

Authors:  P Little; G Girling; A Hasler; A Trafford; A Craven
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

4.  [Nutritional behavior of insulin-dependent diabetes patients studied with the KALI 2.1.2 computer program].

Authors:  F Matzkies; B Webs; R Rusche
Journal:  Z Ernahrungswiss       Date:  1986-03

Review 5.  Dietary fiber prevents carbohydrate-induced hypertriglyceridemia.

Authors:  J W Anderson
Journal:  Curr Atheroscler Rep       Date:  2000-11       Impact factor: 5.113

Review 6.  Glomerular function reserve and sodium sensitivity.

Authors:  Genjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2005-06       Impact factor: 2.801

7.  Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation.

Authors:  P M Dodson; M Beevers; R Hallworth; M J Webberley; R F Fletcher; K G Taylor
Journal:  BMJ       Date:  1989-01-28

Review 8.  Hypertension in the diabetic patient. Selection and optimum use of antihypertensive drugs.

Authors:  B N Trost
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

9.  Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses.

Authors:  Andrew N Reynolds; Ashley P Akerman; Jim Mann
Journal:  PLoS Med       Date:  2020-03-06       Impact factor: 11.069

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.